Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD)

Neuroscience and Biobehavioral Reviews

Volumn 24, Issue 1, 2000, Pages 31-39

  Sagvolden, Terje ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

ADHD; Amphetamine; Hyperkinesis; Psychomotor stimulants; Ritalin

Indexed keywords

DEXAMPHETAMINE; METHYLPHENIDATE; PEMOLINE; PSYCHOSTIMULANT AGENT; SELEGILINE;

ANIMAL MODEL; ATTENTION DEFICIT DISORDER; BEHAVIOR; CHILD; CONFERENCE PAPER; ENVIRONMENTAL FACTOR; GENETICS; HUMAN; HYPERACTIVITY; IMPULSIVENESS; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPTOMATOLOGY; THEORY; VALIDATION PROCESS;

ANIMALS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; HUMANS; RATS; RATS, INBRED SHR;

EID: 0033962321     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(99)00058-5     Document Type: Conference Paper

References (71)

1. Sagvolden T., Sergeant J.A. Attention deficit/hyperactivity disorder - from brain dysfunctions to behaviour. Behav Brain Res. 94:1998;1-10.
2. McKinney W.T., Bunney W.E. Animal model of depression. Arch Gen Psychiat. 21:1969;240-248.
3. Puumala T., Ruotsalainen S., Jakala P., Koivisto E., Riekkinen P. Jr, Sirviö J. Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder. Neurobiol Learn Mem. 66:1997;198-211.
4. Robbins T.W., Jones G.H., Sahakian B.J. Central stimulants, transmitters and attentional disorder: a perspective from animal studies. Sagvolden T., Archer T. Attention deficit disorder: clinical and basic research. 1989;199-222 Lawrence Erlbaum, Hillsdale, NJ.
5. Silbergeld E.K., Goldberg A.M. Lead-induced behavioral dysfunction: an animal model of hyperactivity. Exp Neurol. 42:1974;146-157.
6. Holene E., Nafstad I., Skaare J.U., Bernhoft A., Engen P., Sagvolden T. Behavioral effects of pre- and postnatal exposure to individual polychlorinated biphenyl congeners in rats. Environ Toxicol Chem. 14:1995;967-976.
7. Holene E., Nafstad I., Skaare J.U., Sagvolden T. Behavioural hyperactivity in rats following postnatal exposure to sub-toxic doses of polychlorinated biphenyl congeners 153 and 126. Behav Brain Res. 94:1998;213-224.
8. Dell'Anna M.E., Luthman J., Lindqvist E., Olson L. Development of monoamine systems after neonatal anoxia in rats. Brain Res Bull. 32:1993;159-170.
9. Diaz-Granados J.L., Greene P.L., Amsel A. Selective activity enhancement and persistence in weanling rats after hippocampal X-irradiation in infancy: possible relevance for ADHD. Behav Neural Biol. 61:1994;251-259.
10. Archer T. Neurotoxin-induced cognitive and motor activity modifications: a catecholamine connection. Sagvolden T., Archer T. Attention deficit disorder: clinical and basic research. 1989;287-322 Lawrence Erlbaum, Hillsdale, NJ.
11. Shaywitz B.A., Klopper J.H., Yager R.D., Gordon J.W. Paradoxical response to amphetamine in developing rats treated with 6-hydroxydopamine. Nature. 261:1976;153-155.
12. Shaywitz B.A., Yager R.D., Klopper J.H. Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Science. 191:1976;305-308.
13. Berger D.F., Sagvolden T. Sex differences in operant discrimination behaviour in an animal model of attention-deficit hyperactivity disorder. Behav Brain Res. 94:1998;73-82.
14. Boix F., Qiao S.-W., Kolpus T., Sagvolden T. Chronic L-deprenyl treatment alters brain monoamine levels and reduces impulsiveness in an animal model of attention-deficit/hyperactivity disorder. Behav Brain Res. 94:1998;153-162.
15. Knardahl S., Sagvolden T. Open-field behavior of spontaneously hypertensive rats. Behav Neural Biol. 27:1979;187-200.
16. McCarty R., Kopin I.J. Patterns of behavioral development in spontaneously hypertensive rats and Wistar-Kyoto normotensive controls. Dev Psychobiol. 12:1979;239-243.
17. Mook D.M., Jeffrey J., Neuringer A. Spontaneously hypertensive rats (SHR) readily learn to vary but not repeat instrumental responses. Behav Neural Biol. 59:1993;126-135.
18. Moser M.-B., Moser E.I., Wultz B., Sagvolden T. Component analyses differentiate between exploratory behaviour of spontaneously hypertensive rats and Wistar Kyoto rats in a two- compartment free-exploration open field. Scand J Psychol. 29:1988;200-206.
19. Myers M.M., Musty R.E., Hendley E.D. Attenuation of hyperactivity in the spontaneously hypertensive rat by amphetamine. Behav Neural Biol. 34:1982;42-54.
20. Sagvolden T., Hendley E.D., Knardahl S. Behavior of hypertensive and hyperactive rat strains: Hyperactivity is not unitarily determined. Physiol Behav. 52:1992;49-57.
21. Sagvolden T., Metzger M.A., Sagvolden G. Frequent reward eliminates differences in activity between hyperkinetic rats and controls. Behav Neural Biol. 59:1993;225-229.
22. Sagvolden T., Metzger M.A., Schiørbeck H.K., Rugland A.L., Spinnangr I., Sagvolden G. The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants. Behav Neural Biol. 58:1992;103-112.
23. Sagvolden T., Pettersen M.B., Larsen M.C. Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strains. Physiol Behav. 54:1993;1047-1055.
24. Wultz B., Sagvolden T. The hyperactive spontaneously hypertensive rat learns to sit still, but not to stop bursts of responses with short interresponse times. Behav Genet. 22:1992;415-433.
25. Wultz B., Sagvolden T., Moser E.I., Moser M.-B. The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior. Behav Neural Biol. 53:1990;88-102.
26. Sadile A.G. What can genetic models tell us about behavioral plasticity. Rev Neurosci. 4:1993;287-303.
27. Sadile A.G., Pellicano M.P., Sagvolden T., Sergeant J.A. NMDA and non-NMDA sensitive [L-3H] glutamate receptor binding in the brain of the Naples high- and low-excitability rats: an autoradiographic study. Behav Brain Res. 78:1996;163-174.
28. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
29. Okamoto K., Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn Circ J. 27:1963;282-293.
30. Hendley E.D. WKHA rats with genetic hyperactivity and hyperreactivity to stress: a review. Neurosci Biobehav Rev. 24:2000;41-44.
31. Hendley E.D., Wessel D.J., Van Houten J. Inbreeding of Wistar-Kyoto rat strain with hyperactivity but without hypertension. Behav Neural Biol. 45:1986;1-16.
32. Sarter M., Hagan J., Dudchenko P. Behavioral screening for cognition enhancers: from indiscriminate to valid testing: part I. Psychopharmacology. 107:1992;144-159.
33. Willner P. The validity of animal models of depression. Psychopharmacology. 83:1984;1-16.
34. Willner P. Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case. Progress Neuro-Psychopharmacology Biol Psychiat. 10:1986;677-690.
35. Taylor E. Clinical foundations of hyperactivity research. Behav Brain Res. 94:1998;11-24.
36. Sagvolden T., Aase H., Zeiner P., Berger D.F. Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder. Behav Brain Res. 94:1998;61-71.
37. Sergeant J.A., van der Meere J.J. Convergence of approaches in localizing the hyperactivity deficit. Lahey B.B., Kazdin A.E. Advancements in clinical psychology. 1990;207-245 Plenum, New York.
38. Sergeant J.A., Scholten C.A. On data limitations on hyperactivity. J Child Psychol Psychiatry. 26:1985;111-124.
39. Douglas V.I. Attentional and cognitive problems. Rutter M. Developmental neuropsychiatry. 1983;280-329 Guilford Press, New York.
40. van der Meere J.J. The role of attention. Sandberg S.T. Monographs in child and adolescent psychiatry. Hyperactivity disorders of childhood. 1996;109-146 Cambridge University Press, Cambridge.
41. Porrino L.J., Rapoport J.L., Behar D., Sceery W., Ismond D.R., Bunney W.E. A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls. Arch Gen Psychiat. 40:1983;681-687.
42. Sleator E.K., Ullman R.K. Can a physician diagnose hyperactivity in the office? Pediatrics. 67:1981;13-17.
43. Evenden JL. Serotonergic and Steroidal Influences on impulsive behaviour in rats. University of Uppsala, 1998, thesis.
44. Oosterlaan J., Sergeant J.A. Response inhibition and response re-engagement in ADHD, disruptive, anxious and normal children. Behav Brain Res. 94:1998;33-43.
45. Rubia K., Oosterlaan J., Sergeant J.A., Brandeis D., van Leeuwen T. Inhibitory dysfunction in hyperactive boys. Behav Brain Res. 94:1998;25-32.
46. Stinus L., Cador M., Le Moal M. Interaction between endogenous opioids and dopamine within the nucleus accumbens. Ann NY Acad Sci. 654:1992;254-273.
47. Cook E.H. Jr, Stein M.A., Krasowski M.D., Cox N.J., Olkon D.M., Kieffer J.E., Leventhal B.L. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet. 56:1995;993-998.
48. LaHoste G.J., Swanson J.M., Wigal S.B., Glabe C., Wigal T., King N., Kennedy J.L. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol. Psychiatry. 1:1996;121-124.
49. Swanson J.M., Flodmin P., Kennedy J., Spence M.A., Moyzis R., Schuck S., Marias M., Moriaty J., Barr C., Smith M., Posner M. Dopamine genes and ADHD. Neurosci Biobehav Rev. 24:2000;21-25.
50. Carey M.P., Diewald L.M., Esposito F., Pellicano M.P., Gironi Carnevale U.A., Sergeant J.A., Papa M., Sadile A.G. Differential distribution, affinity and plasticity of dopamine D-1 and D-2 receptors in the target sites of the mesolimbic system in an animal model of ADHD. Behav Brain Res. 94:1998;173-185.
51. Linthorst A.C.E., De Lang H., De Jong W., Versteeg D.H. Effect of the dopamine D2 receptor agonist quinpirole on the vivo release of dopamine in the caudate nucleus of hypertensive rats. Eur J Pharmacol. 201:1991;125-133.
52. Russell V., de Villiers A., Sagvolden T., Lamm M., Taljaard J. Differences between electrically-, ritalin- and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of attention-deficit hyperactivity disorder. Behav Brain Res. 94:1998;163-171.
53. Russell V.A. The nucleus accumbens motor-limbic interface of the spontaneously hypertensive rat (SHR) as studied in-vitro by the superfusion slice technique. Neurosci Biobehav Rev. 24:2000;133-136.
54. Sadile A.G. Multiple evidence of a segmental defect in the anterior forebrain of an animal model of hyperactivity and attention deficits. Neurosci Biobehav Rev. 24:2000;161-169.
55. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Sciences of the United States of America. 85:1988;5274-5278.
56. Douglas V.I., Parry P.A. Effects of reward and nonreward on frustration and attention in attention deficit disorder. J Abnorm Child Psychol. 22:1994;281-301.
57. Sagvolden T. The attention deficit disorder might be a reinforcement deficit disorder. Georgas J., Manthouli M., Besevegis E., Kokkevi A. Contemporary psychology in Europe: theory, research, and application. 1996;131-143 Hogrefe and Huber, Gottingen.
58. Sagvolden T., Archer T. Future perspectives on ADD research - an irresistible challenge. Sagvolden T., Archer T. Attention deficit disorder: clinical and basic research. 1989;369-389 Lawrence Erlbaum, Hillsdale, NJ.
59. Sonuga-Barke E.J.S., Taylor E., Sembi S., Smith J. Hyperactivity and delay aversion I: the effect of delay on choice. J Child Psychol Psychiatry. 33:1992;387-398.
60. Wender P.H. Minimal brain dysfunction in children. 1971;Wiley, New York.
61. Catania A.C., Sagvolden T., Keller K.J. Reinforcement schedules: retroactive and proactive effects of reinforcers inserted into fixed-interval performance. J Exp Anal Behav. 49:1988;49-73.
62. Catania A.C. Reinforcement schedules: the role of responses preceding the one that produces the reinforcer. J Exp Anal Behav. 15:1971;271-287.
63. Saldana R.L., Neuringer A. Is instrumental variability abnormally high in children exhibiting ADHD and aggressive behavior? Behav Brain Res. 94:1998;51-59.
64. Catania A.C. Learning. 1992;Prentice-Hall, Englewood Cliffs, NJ.
65. Catania A.C., Sagvolden T., Aase H. Delay of reinforcement and the hyperactivity syndrome. Society for the Quantitative Analysis of Behavior. 1997;8. Abstract.
66. Papa M., Berger D.F., Sagvolden T., Sergeant J.A., Sadile A.G. A quantitative cytochrome oxidase mapping study, cross-regional and neurobehavioural correlations in the anterior forebrain of an animal model of attention deficit hyperactivity disorder. Behav Brain Res. 94:1998;197-211.
67. Solanto-Gardner M.V. Clinical psychopharmacology of AD/HD: implications for animal models. Neurosci Biobehav Rev. 24:2000;27-30.
68. Solanto M.V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res. 94:1998;127-152.
69. de Villiers A.S., Russell V.A., Sagvolden T., Searson A., Jaffer A., Taljaard J.J.F. Alpha2-adrenoceptor mediated inhibition of [3H] dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention deficit hyperactivity disorder. Neurochem Res. 20:1995;357-363.
70. Russell V., de Villiers A., Sagvolden T., Lamm M., Taljaard J. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Brain Res. 676:1995;343-351.
71. Sagvolden T., Slåtta K., Arntzen E. Low doses of methylphenidate (Ritalin) may alter the delay-of- reinforcement gradient. Psychopharmacology (Berlin). 95:1988;303-312.